Work

Cellular Immunity in Recombinant Adeno-Associated Virus Vector Mediated Gene Therapy

Year: 2011
Type: article
Abstract: Recombinant adeno-associated virus (rAAV) is a promising gene therapy vector that mediates effective in vivo gene delivery.Only recently has the field of gene therapy begun to appreciate that one of the major challenges to the success of rAAV-mediated gene correction is the host immune response.Not only is the rAAV capsid protein a potential target of immunity, the therapeutic protein encoded by the transgene may also be recognized as non-self.The goal of studies reported herein is twofold: (i) to elucidate the mechanisms of antigen presentation relevant to the priming and maintenance of CD8 + T cells specific to the vector capsid and transgene-encoded proteins in murine models; and (ii) to provide insight into the function, kinetics, and fate of these CD8 + T cells, particularly those that infiltrated vector-transduced muscle, in mice and non-human primates.We have demonstrated that dendritic cells are required to prime CD8 + T cells specific to the vector capsid and the transgene-encoded protein.Priming of capsid-specific CD8 + T cells was not sustained when the antigen was not encoded by the vector-delivered transgene.On the other hand, a transgene antigen-specific CD8 + T-cell response was perpetuated through cross-priming by dendritic cells that continuously acquired the transgene-encoded proteins from vector-transduced muscle.iii Transient infiltration of fully functional capsid-specific CD8 + T cells in vector-transduced muscle failed to eliminate transgene-expressing myocytes.This is because transduced myocytes, at least in mice, were unable to present capsid epitopes in the context of class I MHC (major histocompatibility complex) for CD8 + T-cell recognition.However, whether capsid can be processed for class I presentation by vector-transduced target cells in higher order species with diverse MHC haplotypes remains unknown.Thus, to minimize the risks of target-cell killing by capsid-specific CD8 + T cells, we tested a novel approach capable of permanently silencing functional capsid-specific CD8 + T cells in the transduced tissue through sustained expression of class I capsid epitopes from the transgene.Our investigation of the long-lasting CD8 + T cells specific to the transgene-encoded proteins in non-human primates revealed that they have a phenotype resembling effector cells, but are functionally comparable to memory cells.These CD8 + T cells, therefore, presented potential risks in elimination of transgene-expressing cells.In summary, we documented in chapter 2 that dendritic cells were required for priming and maintenance of CD8 + T cells specific to the rAAV vector-delivered antigens.Our findings suggest that CD8 + T cells targeting the vector capsid and the transgene-encoded protein have the potential to limit persistent transgene expression.The capsid-specific Tcell response is perhaps manageable, if it is silenced by approaches described in chapter 3 of this dissertation.The transgene antigen-specific CD8 + T cells were fully functional, at My most sincere gratitude goes to my advisor, Dr. Christopher Walker, who has far more patience with me than I deserve.He taught me how to ask the right questions and put things in perspective.His erudite guidance and continuous encouragement helped me overcome numerous hurdles so that I could make it this far.I am forever grateful for his tireless reading of my countless drafts and all the efforts he has invested in the improvement of my scientific writing.I am privileged to have such an advisor, who gave me the full freedom to enjoy the beauty of science and upheld me when I faltered.He has set an incredible role model for me as a scientist and a mentor that will be difficult to surpass.My graduate committee members, Dr.
Author: Dan Xu
Language: English
Subfield: Genetics
Open Access status: green
OpenAlex ID: W2598013790
FWCI:
Cites: 101
Cited by:
Related to: 9